Livzon Pharma discloses share repurchase activities in next day return

Livzon Pharmaceutical Group Inc. (HKEX: 1513) has filed a Next Day Disclosure Return, detailing changes in its ordinary shares. The company's H shares remained at 307,052,417. During April 2025, the company repurchased shares but did not cancel them. Specifically, A shares repurchased totaled 144,900 for a total aggregate price of RMB4,997,667, with prices ranging between RMB34.24 and RMB34.63. These repurchases were executed on the Shenzhen Stock Exchange. These A shares, while repurchased, are not yet cancelled as of April 15, 2025.